A Prospective Study About Trastuzumab-induced Cardiotoxicity in HER2-positive Breast Cancer

Abstract

In patients with BC treated with trastuzumab, in addition to the evaluation of the LVEF, systolic longitudinal strain, TNI, and NT pro-BNP measured at the completion of anthracyclines are useful in the prediction of subsequent TIC.